Editorial: New insights into inflammation driven autoimmune skin disorders: trends and challenges

• by Manoj Kumar Tembhre, Alpana Sharma, Pankaj Dipankar, Shanid Mohiyuddin, Mohammad Tarique, Suneel Kumar

• July 7, 2026

FDA Expands Pediatric Roflumilast Use

The expanded indication is supported by pharmacokinetic, safety, tolerability, exploratory efficacy, and long-term safety data from studies in children aged 2 to 5 years.

• by Kathryn Wighton

• June 30, 2026

• 3 min

Psoriasis as a systemic inflammatory disease: an immune set-point framework for comorbidities and relapse

• by Jingyi Ma, Haoyu Li, Xueqi Yang, Yuzhe Cheng, Bingran Qi, Siyu Kang, He Qi, Ruiqun Qi, Jun Niu

• May 15, 2026

Case Report: Local injection of an IL-17 inhibitor successfully treats Acrodermatitis continua of Hallopeau and avoids immune shift

• by Yali Li, Shiying Li, Yuning Zhang, Yuhan Chen, Tao Guo, Chen Li

• June 9, 2026